Verlängertes Überleben bei Patientinnen mit Ovarialkarzinom und Endometriose

In: TumorDiagnostik & Therapie · 2021 · vol. 42(06) , pp. 403 · doi:10.1055/a-1543-2941 · W4254262265
article OA: closed CC0
Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This study investigated whether co-occurring endometriosis improves survival in ovarian cancer patients, presenting new data to address inconsistent previous findings.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-07, 2026-07-09 · read from full text ⓘ

The paper discusses comparative evidence on outcomes across gynecologic cancers in Europe, noting that ovarian cancer has the highest mortality. It highlights that prior studies have suggested that co-occurring endometriosis may improve the prognosis for patients with ovarian cancer, but that findings are inconsistent. It reports that Hermens and colleagues have presented new data on this question, with the aim of clarifying whether endometriosis is associated with altered survival in ovarian cancer. This paper relates to endometriosis because it focuses on how concomitant endometriosis may influence survival/prognosis in ovarian cancer patients, while also emphasizing that prior results have been heterogeneous.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Bei einem Vergleich gynäkologischer Krebserkrankungen in Europa geht das Ovarialkarzinom mit der höchsten Mortalität einher. Studienergebnisse deuten darauf hin, dass eine gleichzeitig auftretende Endometriose die Prognose von Ovarialkarzinompatientinnen verbessert – allerdings sind die Ergebnisse uneinheitlich. Hermens et al. haben hierzu neue Daten vorgelegt.
Full text 857 characters · extracted from oa-doi-fallback · click to expand
Subscribe to RSS Please copy the URL and add it into your RSS Feed Reader. https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000088.xml TumorDiagnostik & Therapie 2021; 42(06): 403 DOI: 10.1055/a-1543-2941 DOI: 10.1055/a-1543-2941 Aktuell referiert Verlängertes Überleben bei Patientinnen mit Ovarialkarzinom und Endometriose Bei einem Vergleich gynäkologischer Krebserkrankungen in Europa geht das Ovarialkarzinom mit der höchsten Mortalität einher. Studienergebnisse deuten darauf hin, dass eine gleichzeitig auftretende Endometriose die Prognose von Ovarialkarzinompatientinnen verbessert – allerdings sind die Ergebnisse uneinheitlich. Hermens et al. haben hierzu neue Daten vorgelegt. Publication History Article published online: 29 July 2021 © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

die_deep_infiltrating

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

References (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK